David H. Raulet | Academic Influence

David H. Raulet's AcademicInfluence.com Rankings

David H. Raulet

Biology

#2473

World Rank

#3914

Historical Rank

Immunology

#169

World Rank

#177

Historical Rank

biology Degrees

Download Badge

Biology

David H. Raulet's Degrees

PhD Immunology University of California, Berkeley
Bachelors Biology University of California, Berkeley

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2025

Why Is David H. Raulet Influential?

(Suggest an Edit or Addition)

According to Wikipedia, David H. Raulet is an immunologist who specializes in studying the role of natural killer cells. He is a professor in the Department of Molecular and Cell Biology at the University of California, Berkeley where he also holds the Esther and Wendy Schekman Chair in cancer biology. He was elected to the National Academy of Sciences in 2019. Raulet is also the co-founder of Dragonfly Therapeutics, a company that seeks to use natural killer cells for cancer immunotherapy.

(See a Problem?)

David H. Raulet's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Innate or Adaptive Immunity? The Example of Natural Killer Cells (2011) (2313)
CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones (1992) (1679)
Roles of the NKG2D immunoreceptor and its ligands (2003) (1373)
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor (2005) (1326)
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity (2001) (1108)
β2-Microglobulin deficient mice lack CD4−8+ cytolytic T cells (1990) (1044)
Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages (2000) (945)
Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. (2004) (828)
Developmental potential and dynamic behavior of hematopoietic stem cells (1986) (826)
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. (2008) (762)
Regulation of ligands for the NKG2D activating receptor. (2013) (666)
The role of the NKG2D immunoreceptor in immune cell activation and natural killing. (2002) (665)
A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. (2005) (618)
Regulation of the natural killer cell receptor repertoire. (2001) (603)
Self-tolerance of natural killer cells (2006) (602)
Mouse CD94/NKG2A Is a Natural Killer Cell Receptor for the Nonclassical Major Histocompatibility Complex (MHC) Class I Molecule Qa-1b (1998) (546)
Properties and applications of monoclonal antibodies directed against determinants of the Thy-1 locus. (1979) (544)
Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D (2002) (491)
MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. (1991) (487)
Developmental regulation of T-cell receptor gene expression (1985) (480)
Interplay of natural killer cells and their receptors with the adaptive immune response (2004) (461)
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade (2018) (447)
Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice (1991) (430)
The structure, function, and molecular genetics of the gamma/delta T cell receptor. (1989) (423)
Diversity, rearrangement, and expression of murine T cell gamma genes (1986) (400)
Oncogenic stress sensed by the immune system: role of natural killer cell receptors (2009) (378)
Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. (1999) (366)
The MHC Reactivity of the T Cell Repertoire Prior to Positive and Negative Selection (1997) (355)
B-cell-stimulatory factor 2 (beta 2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells. (1987) (330)
Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells. (2016) (319)
Recognition of tumors by the innate immune system and natural killer cells. (2014) (307)
p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) (296)
NK Cell Responsiveness Is Tuned Commensurate with the Number of Inhibitory Receptors for Self-MHC Class I: The Rheostat Model 1 (2009) (279)
Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I‐specific Ly49 receptors (1997) (274)
Viral Infections Induce Abundant Numbers of Senescent CD8 T Cells1 (2001) (266)
Tumor‐Derived cGAMP Triggers a STING‐Mediated Interferon Response in Non‐tumor Cells to Activate the NK Cell Response (2018) (256)
Recognition of the Class Ib Molecule Qa-1b by Putative Activating Receptors Cd94/Nkg2c and Cd94/Nkg2e on Mouse Natural Killer Cells (1999) (253)
Evidence for a stochastic mechanism in the differentiation of mature subsets of T lymphocytes (1993) (248)
The innate immune response to tumors and its role in the induction of T‐cell immunity (2002) (246)
Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment (2010) (245)
Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors. (2004) (243)
NK1.1+ T Cells in the Liver Arise in the Thymus and Are Selected by Interactions with Class I Molecules on CD4+CD8+ Cells1 (2000) (243)
Strategies for target cell recognition by natural killer cells (2001) (241)
Activation and self‐tolerance of natural killer cells (2006) (235)
A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection (2015) (213)
Allelic exclusion of Ly49-family genes encoding class I MHC-specific receptors on NK cells (1995) (210)
Cutting Edge: Tumor Rejection Mediated by NKG2D Receptor-Ligand Interaction Is Dependent upon Perforin1 (2002) (206)
Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. (1995) (200)
Acquisition of Ly49 Receptor Expression by Developing Natural Killer Cells (1998) (200)
Turnover and Proliferation of NK Cells in Steady State and Lymphopenic Conditions1 (2004) (199)
NK Cells Respond to Pulmonary Infection with Mycobacterium tuberculosis, but Play a Minimal Role in Protection 1 (2003) (198)
Expression and function of interleukin-2 receptors on immature thymocytes (1985) (197)
A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity (2003) (185)
Expression and function of NK cell receptors in CD8+ T cells. (2001) (183)
The DNA damage response arouses the immune system. (2006) (182)
SLC19A1 transports immunoreactive cyclic dinucleotides (2019) (176)
Positive selection of V beta 8+ CD4-8- thymocytes by class I molecules expressed by hematopoietic cells (1993) (175)
Natural killer cell receptors: The offs and ons of NK cell recognition (1995) (172)
Class I dependence of the development of CD4+ CD8- NK1.1+ thymocytes (1994) (167)
NK cell self tolerance, responsiveness and missing self recognition. (2014) (166)
Major histocompatibility complex class I‐dependent skewing of the natural killer cell Ly49 receptor reportoire (1996) (163)
Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors (2004) (163)
Memory CD8 T lymphocytes express inhibitory MHC‐specific Ly49 receptors (2000) (160)
Development and selection of γδ T cells (2007) (158)
Missing self recognition and self tolerance of natural killer (NK) cells. (2006) (158)
Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection (1996) (155)
Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC. (2000) (152)
Cytokine therapy reverses NK cell anergy in MHC-deficient tumors. (2014) (151)
A differentiation factor required for the expression of cytotoxic T-cell function (1982) (151)
Functionally conformed free class I heavy chains exist on the surface of beta 2 microglobulin negative cells (1992) (149)
Regulation of NK cell responsiveness to achieve self‐tolerance and maximal responses to diseased target cells (2008) (149)
Viral and Bacterial Infections Induce Expression of Multiple NK Cell Receptors in Responding CD8+ T Cells1 (2002) (146)
Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases (2006) (145)
The DNA damage response, immunity and cancer. (2006) (141)
Cloning of a mouse homolog of CD94 extends the family of C‐type lectins on murine natural killer cells (1997) (139)
Inefficient positive selection of T cells directed by haematopoietic cells (1992) (138)
Positive selection determines T cell receptor V beta 14 gene usage by CD8+ T cells (1989) (137)
Most gamma delta T cells develop normally in beta 2-microglobulin-deficient mice. (1992) (133)
Analysis of Qa-1bPeptide Binding Specificity and the Capacity of Cd94/Nkg2a to Discriminate between Qa-1–Peptide Complexes (2000) (126)
Evidence That γδ versus αβ T Cell Fate Determination Is Initiated Independently of T Cell Receptor Signaling (2001) (121)
MHC class I-deficient mice. (1994) (120)
Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire. (1996) (117)
Ly49A Transgenic Mice Provide Evidence for a Major Histocompatibility Complex–dependent Education Process in Natural Killer Cell Development (1997) (116)
Cytotoxic T lymphocytes produce immune interferon in response to antigen or mitogen (1982) (116)
RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry (2012) (115)
Ordered rearrangement of variable region genes of the T cell receptor gamma locus correlates with transcription of the unrearranged genes (1993) (115)
RAE1 ligands for the NKG2D receptor are regulated by STING-dependent DNA sensor pathways in lymphoma. (2014) (115)
CD28-induced costimulation of T helper type 2 cells mediated by induction of responsiveness to interleukin 4 (1993) (114)
NK cell expression of the killer cell lectin‐like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules (2000) (113)
Class I-deficient hemopoietic cells and nonhemopoietic cells dominantly induce unresponsiveness of natural killer cells to class I-deficient bone marrow cell grafts. (1997) (111)
Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress (2009) (108)
Development and tolerance of natural killer cells. (1999) (105)
The basis for self-tolerance of natural killer cells in beta2-microglobulin- and TAP-1- mice. (1997) (104)
Positive Selection of Dendritic Epidermal γδ T Cell Precursors in the Fetal Thymus Determines Expression of Skin-Homing Receptors (2004) (103)
Multiplicity and plasticity of natural killer cell signaling pathways. (2006) (103)
Development and selection of gammadelta T cells. (2007) (101)
Chemotherapy-induced genotoxic stress promotes sensitivity to natural killer cell cytotoxicity by enabling missing-self recognition. (2010) (100)
Fractionation of lymphocyte populations with monoclonal antibodies specific for LYT-2.2 and LYT-3.1. (1980) (99)
IL-6 and IL-1 synergize to stimulate IL-2 production and proliferation of peripheral T cells. (1989) (99)
Expression of human adenosine deaminase in mice reconstituted with retrovirus-transduced hematopoietic stem cells. (1990) (97)
Endoplasmic Reticulum Aminopeptidase Associated with Antigen Processing Defines the Composition and Structure of MHC Class I Peptide Repertoire in Normal and Virus-Infected Cells (2010) (97)
Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation (2002) (95)
Selection is not required to produce invariant T-cell receptor γ-gene junctional sequences (1993) (95)
Antigens for γ/δ T cells (1989) (94)
Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor. (1999) (92)
Innate immune recognition by stimulatory immunoreceptors. (2003) (92)
2F1 antigen, the mouse homolog of the rat “mast cell function‐associated antigen”, is a lectin‐like type II transmembrane receptor expressed by natural killer cells (1998) (89)
Multiple natural killer cell‐activating signals are inhibited by major histocompatibility complex class I expression in target cells (1994) (88)
Murine Cytomegalovirus Interference with Antigen Presentation Has Little Effect on the Size or the Effector Memory Phenotype of the CD8 T Cell Response1 (2004) (87)
The Developmental Fate of T Cells Is Critically Influenced by TCRγδ Expression (1998) (84)
NK cells mediate clearance of CD8+ T cell–resistant tumors in response to STING agonists (2020) (84)
Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging. (2019) (83)
Events that regulate differentiation of αβ TCR+and γδ TCR+T cells from a common precursor (1997) (82)
Costimulation of Dendritic Epidermal γδ T Cells by a New NKG2D Ligand Expressed Specifically in the Skin 1 (2009) (82)
Immunosurveillance and immunotherapy of tumors by innate immune cells. (2016) (80)
The role of viral enhancer "core" motif-related sequences in regulating T cell receptor-gamma and -delta gene expression. (1993) (75)
Major histocompatibility complex genes determine natural killer cell tolerance (1996) (75)
Defective Development of γ/δ T Cells in Interleukin 7 Receptor–Deficient Mice Is Due to Impaired Expression of T Cell Receptor γ Genes (1999) (75)
Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient mice. (2012) (74)
Control of γδ T‐Cell Development (1991) (73)
Expression of the Ly49A gene in murine natural killer cell clones is predominantly but not exclusively mono‐allelic (1997) (71)
Positive selection of dendritic epidermal gammadelta T cell precursors in the fetal thymus determines expression of skin-homing receptors. (2004) (71)
Redundant and Unique Roles of Two Enhancer Elements in the TCRγ Locus in Gene Regulation and γδ T Cell Development (2002) (66)
MHC‐dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: evidence for a regulated sequential model (2001) (62)
T‐Cell Lineages, Repertoire Selection and Tolerance Induction (1988) (62)
Stress-Regulated Targeting of the NKG2D Ligand Mult1 by a Membrane-Associated RING-CH Family E3 Ligase (2010) (61)
Orderly and Nonstochastic Acquisition of CD94/NKG2 Receptors by Developing NK Cells Derived from Embryonic Stem Cells In Vitro1 (2002) (60)
Endothelial cells express NKG2D ligands and desensitize antitumor NK responses (2017) (59)
IFN-γ-mediated negative feedback regulation of NKT cell function by CD94/NKG2 (2005) (58)
Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. 1990. (2010) (58)
Evidence that productive rearrangements of TCR γ genes influence the commitment of progenitor cells to differentiate into αβ or γδ T cells (1995) (58)
The role of short homology repeats and TdT in generation of the invariant γδ antigen receptor repertoire in the fetal thymus (1995) (58)
Expression of the RAE-1 Family of Stimulatory NK-Cell Ligands Requires Activation of the PI3K Pathway during Viral Infection and Transformation (2011) (57)
Immune Activation Resulting From NKG2D/Ligand Interaction Promotes Atherosclerosis (2011) (53)
ATM-dependent spontaneous regression of early Eμ-myc-induced murine B-cell leukemia depends on natural killer and T cells. (2013) (53)
Immune surveillance of unhealthy cells by natural killer cells. (2013) (52)
Developmentally Programmed Rearrangement of T Cell Receptor Vγ Genes Is Controlled by Sequences Immediately Upstream of the Vγ Genes (1998) (52)
Recognition events that inhibit and activate natural killer cells. (1996) (51)
NKG2D Mediates NK Cell Hyperresponsiveness and Influenza-Induced Pathologies in a Mouse Model of Chronic Obstructive Pulmonary Disease (2012) (50)
Infection-induced regulation of natural killer cells by macrophages and collagen at the lymph node subcapsular sinus. (2012) (50)
The role of c-Myb or a related factor in regulating the T cell receptor gamma gene enhancer. (1995) (49)
T-cell receptor variable region gene usage in T-cell populations. (1986) (48)
Evidence for Natural Killer Cell Memory (2013) (48)
An RNA-Based Fluorescent Biosensor for High-Throughput Analysis of the cGAS-cGAMP-STING Pathway. (2016) (47)
Role of IL-6, IL-1, and CD28 signaling in responses of mouse CD4+ T cells to immobilized anti-TCR monoclonal antibody. (1994) (47)
NK cells developing in vitro from fetal mouse progenitors express at least one member of the Ly49 family that is acquired in a time‐dependent and stochastic manner independently of CD94 and NKG2 (2002) (46)
Predominant variable region gene usage by gamma/delta T cell receptor- bearing cells in the adult thymus (1988) (46)
Class I MHC molecules on hematopoietic cells can support intrathymic positive selection of T cell receptor transgenic T cells. (1999) (46)
The Role of Innate Immunity in Autoimmunity (2004) (44)
Expression of Natural Killer Receptor Alleles at Different Ly49 Loci Occurs Independently and Is Regulated by Major Histocompatibility Complex Class I Molecules (2001) (44)
Bacterial Manipulation of NK Cell Regulatory Activity Increases Susceptibility to Listeria monocytogenes Infection (2016) (44)
Expression of the V beta 5.1 gene by murine peripheral T cells is controlled by MHC genes and skewed to the CD8+ subset. (1990) (43)
A selective role of NKG2D in inflammatory and autoimmune diseases. (2013) (43)
Dysregulated cellular functions and cell stress pathways provide critical cues for activating and targeting natural killer cells to transformed and infected cells (2017) (43)
Stromal-cell regulation of natural killer cell differentiation (2007) (43)
NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT. (2015) (41)
Genomic Ly49A Transgenes: Basis of Variegated Ly49A Gene Expression and Identification of a Critical Regulatory Element1 (2004) (41)
T Cell Receptor γ Gene Regulatory Sequences Prevent the Function of a Novel TCRγ/pTα Pre–T Cell Receptor (1998) (41)
Cumulative Inhibition of NK Cells and T Cells Resulting from Engagement of Multiple Inhibitory Ly49 Receptors1 (2001) (39)
Inhibition of MHC Class I Is a Virulence Factor in Herpes Simplex Virus Infection of Mice (2005) (39)
A forward genetic screen reveals novel independent regulators of ULBP1, an activating ligand for natural killer cells (2015) (39)
NKG2A Inhibits Invariant NKT Cell Activation in Hepatic Injury1 (2009) (38)
Characterization of a novel NKG2D and NKp46 double-mutant mouse reveals subtle variations in the NK cell repertoire. (2013) (37)
Expansion and Function of CD8+ T Cells Expressing Ly49 Inhibitory Receptors Specific for MHC Class I Molecules1 (2004) (37)
Blastocyst MHC, a Putative Murine Homologue of HLA-G, Protects TAP-Deficient Tumor Cells from Natural Killer Cell-Mediated Rejection In Vivo1 (2003) (37)
The genomic arrangement of T cell receptor variable genes is a determinant of the developmental rearrangement pattern (2003) (36)
Natural killer cells: Stress out, turn on, tune in (1999) (36)
A sense of something missing (1992) (36)
A Novel Element Upstream of the Vγ2 Gene in the Murine T Cell Receptor γ Locus Cooperates with the 3′ Enhancer to Act as a Locus Control Region (1999) (35)
The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells. (2019) (35)
Identification of a T-cell-specific transcriptional enhancer located 3' of C gamma 1 in the murine T-cell receptor gamma locus. (1991) (35)
p 53-dependent chemokine production by senescent tumor cells supports NKG 2 D-dependent tumor elimination by natural killer cells (2013) (34)
Redundant and unique roles of two enhancer elements in the TCRgamma locus in gene regulation and gammadelta T cell development. (2002) (34)
IFN-gamma-mediated negative feedback regulation of NKT-cell function by CD94/NKG2. (2005) (33)
Characterization of a novel murine T cell-activating factor. (1987) (33)
Rearrangement by inversion of a T-cell receptor delta variable region gene located 3' of the delta constant region gene. (1989) (30)
Roles of natural killer cells in immunity to cancer, and applications to immunotherapy (2022) (30)
Immunosurveillance of senescent cancer cells by natural killer cells (2014) (29)
The developmental fate of T cells is critically influenced by TCRgammadelta expression. (1998) (29)
NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy (DOI:10.1016/j.immuni.2008.02.016) (2008) (28)
Expression of CD4 in transgenic mice alters the specificity of CD8 cells for allogeneic major histocompatibility complex. (1991) (28)
Helper T cells for cytotoxic T lymphocytes need not be I region restricted (1982) (26)
Innate immune cells in the tumor microenvironment. (2021) (24)
Inhibitory effects of class I molecules on murine NK cells: speculations on function, specificity and self-tolerance. (1995) (24)
Toward a quantitative analysis of the repertoire of class I MHC-specific inhibitory receptors on natural killer cells. (1998) (24)
Gene placement and competition control T cell receptor γ variable region gene rearrangement (2008) (22)
Listening to each other: Infectious disease and cancer immunology (2017) (22)
Evidence That gd versus ab T Cell Fate Determination Is Initiated Independently of T Cell Receptor Signaling (2001) (21)
The combined actions of NK and T lymphocytes are necessary to reject an EGFP+ mesenchymal tumor through mechanisms dependent on NKG2D and IFNγ (2007) (21)
Contrasting roles of DAP10 and KARAP/DAP12 signaling adaptors in activation of the RBL‐2H3 leukemic mast cell line (2003) (21)
Tumor-induced disruption of the blood-brain barrier promotes host death. (2021) (21)
POSITIVE SELECTION DETERMINES T CELL RECEPTOR V 014 GENE USAGE BY CD 8 + T CELLS BY (20)
Cytokine treatment in cancer immunotherapy (2015) (20)
The lymphoproliferative defect in CTLA-4-deficient mice is ameliorated by an inhibitory NK cell receptor. (2002) (20)
The immunobiology of γδ+ T cells (1990) (19)
DNA Mismanagement Leads to Immune System Oversight (2007) (19)
Millikelvin-resolved ambient thermography (2020) (19)
A Herpesviral induction of RAE-1 NKG2D ligand expression occurs through release of HDAC mediated repression (2016) (19)
Upregulation of CD94/NKG2A receptors and Qa-1b ligand during murine cytomegalovirus infection of salivary glands. (2007) (18)
A new monoclonal antibody reactive with several Ly49 NK cell receptors mediates redirected lysis of target cells. (1999) (17)
HLA Reduces Killer Cell Ig-like Receptor Expression Level and Frequency in a Humanized Mouse Model (2013) (17)
Acquisition of Ly 49 Receptor Expression by Developing Natural Killer Cells (1998) (16)
Events that regulate differentiation of alpha beta TCR+ and gamma delta TCR+ T cells from a common precursor. (1997) (15)
Amelioration of acute graft‐versus‐host disease by NKG2A engagement on donor T cells (2005) (14)
Identification of a T-cell-specific transcriptional enhancer located 3' of Cyl in the murine T-cell receptor y locus (14)
Expression of the Mls-1a superantigen results in an increased frequency of V beta 14+ T cells. (1992) (14)
Natural-Killer-like B Cells Display the Phenotypic and Functional Characteristics of Conventional B Cells. (2017) (13)
Microenvironment and Immunology RAE 1 Ligands for the NKG 2 D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma (2014) (13)
Developmentally programmed rearrangement of T cell receptor Vgamma genes is controlled by sequences immediately upstream of the Vgamma genes. (1998) (13)
Near-field Second Harmonic Imaging of Granular Membrane Structures in Natural Killer Cells (2000) (13)
MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor Functions (2017) (13)
The Role of NKG2D Signaling in Inhibition of Cytotoxic T-Lymphocyte Lysis by the Murine Cytomegalovirus Immunoevasin m152/gp40 (2007) (12)
The role of short homology repeats and TdT in generation of the invariant gamma delta antigen receptor repertoire in the fetal thymus. (1995) (12)
T-Cell Immunity: How γδ T cells make a living (1994) (12)
Selection is not required to produce invariant T-cell receptor gamma-gene junctional sequences. (1993) (12)
Rearrangement by inversion of a T-cell receptor 6 variable region gene located 3' of the 6 constant region gene (11)
Does a low level of expression of HLA molecules engender autoimmunity? (1999) (10)
Expression and function of NK cell receptors in CD 8 + T cells (2001) (10)
Cytokine therapy restores antitumor responses of NK cells rendered anergic in MHC I-deficient tumors (2016) (10)
Control of gamma delta T-cell development. (1991) (10)
Tumor-derived CSF-1 induces the NKG2D ligand RAE-1δ on tumor-infiltrating macrophages (2018) (9)
Recombination Signal Sequence-Associated Restriction on TCRδ Gene Rearrangement Affects the Development of Tissue-Specific γδ T Cells1 (2009) (9)
Bone Marrow Cell Rejection, MHC, NK Cells, and Missing Self Recognition: Ain’t That Peculiar (with Apologies to Marvin Gaye) (2015) (9)
Erratum: The role of the NKG2D immunoreceptor in immune cell activation and natural killing (Immunity (July 2002) 17 (19-29)) (2004) (8)
T cells produce TRF in response to Con A and factors in T cell hybridoma supernatants. (1982) (8)
Evidence that productive rearrangements of TCR gamma genes influence the commitment of progenitor cells to differentiate into alpha beta or gamma delta T cells. (1995) (8)
Natural Killer Cells: Remembrances of Things Past (2009) (7)
Killer cells add fire to fuel immunotherapy (2020) (7)
Corrigendum : T cell killing does not require the formation of a stable mature immunological synapse (2002) (6)
T cell receptor gamma gene regulatory sequences prevent the function of a novel TCRgamma/pTalpha pre-T cell receptor. (1998) (6)
Differential Role of Hematopoietic and Nonhematopoietic Cell Types in the Regulation of NK Cell Tolerance and Responsiveness (2016) (6)
Synergy of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I–deficient and MHC I+ tumors (2022) (6)
Developmentally Programmed Rearrangement of T Cell Receptor V g Genes Is Controlled by Sequences Immediately Upstream of the (1998) (5)
PREDOMINANT VARIABLE REGION GENE USAGE BY y/8 T CELL RECEPTOR-BEARING CELLS IN THE ADULT THYMUS (2003) (5)
Immunology. Antigens for gamma/delta T cells. (1989) (5)
Natural killer cell differentiation driven by Tyro 3 receptor tyrosine kinases (2006) (4)
A selective role of NKG 2 D in inflammatory and autoimmune diseases (2013) (4)
Cell Receptor g Gene Regulatory Sequences Prevent the Function of a Novel TCR g / pT a Pre – T Cell Receptor (1998) (4)
Generation of short-term murine natural killer cell clones to analyze Ly49 gene expression. (2000) (4)
A novel gamma delta T cell receptor for antigen adds limited diversity to the gamma delta repertoire in adult thymus. (1989) (4)
Pillars Article: β2-Microglobulin Deficient Mice Lack CD4−8+ Cytolytic T Cells. Nature. 1990. 344: 742–746 (2010) (3)
Corrigendum: Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D (2004) (3)
The immunobiology of gamma delta+ T cells. (1990) (3)
Lymphocyte development in mice deficient for MHC class I expression. (1992) (3)
Tolerance, and more (1987) (3)
Immunobiology of MHC Class I-Deficient Mice (1994) (3)
Transient NKG2D Blockade Attenuates Graft-Versus-Host Disease While Preserving Graft-Versus-Leukemia Effects (2013) (3)
Cancer esearch oenvironment and Immunology motherapy-Induced Genotoxic Stress Promotes sitivity to Natural Killer Cell Cytotoxicity by R bling Missing-Self Recognition (2010) (2)
Selective expression of V delta 6 genes by B2A2- CD4- CD8- T cell receptor gamma/delta thymocytes. (1990) (2)
SLC19A1 is a cyclic dinucleotide transporter (2019) (2)
ReceptorExpression of the LY 49 A Inhibitory Impaired Anti-Viral T Cell Responses Due to AhmedSourdive (1999) (2)
A phosphorylated, disulfide-linked membrane protein in murine cytotoxic T lymphocytes. (1986) (2)
Clonal Acquisition of Inhibitory Ly 49 Receptors on Developing NK Cells Is Successively Restricted and Regulated by Stromal Class I MHC splenic (2000) (2)
Author response: A forward genetic screen reveals novel independent regulators of ULBP1, an activating ligand for natural killer cells (2015) (1)
Author Correction: SLC19A1 transports immunoreactive cyclic dinucleotides (2020) (1)
Combination therapy to enhance NK cell anti-tumor responses (2020) (1)
MinireviewEvidence for Natural Killer Cell Memory (2013) (1)
TRANSPLANTATION NKG 2 D expression by CD 8 1 T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT (2015) (1)
Bélanger S, Tu MM, Rahim MM, et al. Impaired natural killer cell self-education and “missing-self” responses in Ly49-deficient mice. Blood. 2012;120(3):592-602. (2013) (1)
Powerful synergistic effects of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I-deficient and MHC I+ tumors (2021) (1)
Specifically in the Skin NKG2D Ligand Expressed {gamma}{delta} T Cells by a New Costimulation of Dendritic Epidermal (2009) (1)
A subset of natural killer cells achieve self-tolerance without expressing inhibitory receptors specific for self MHC molecules Running title: NK cells lacking inhibitory receptors for self MHC (2005) (1)
T-cell immunity. How gamma delta T cells make a living. (1994) (1)
Title Bacterial Manipulation of NK Cell Regulatory Activity Increases Susceptibility to Listeria monocytogenes Infection (2016) (0)
Regulation of the NKG2D ligand Mult1 by shedding (48.22) (2011) (0)
Binary outcomes of enhancer activity underlie stable random monoallelic expression (2021) (0)
Specific for MHC Class I Molecules Expressing Ly 49 Inhibitory Receptors T Cells + Expansion and Function of CD 8 Brossay and (2004) (0)
Tumor-derived CSF-1 induces the NKG 2 D ligand RAE-1 δ on tumor-infiltrating 1 macrophages 2 3 (2018) (0)
The combined actins of NK and T lymphocytes are necessary to reject a transplantable mesenchymal tumor through mechanisms partly dependent on KG2D (2006) (0)
T-cell receptor variable region gene usage in T-cell populations ( major histocompatibility complex restriction / ribonuclease protection assay ) (2003) (0)
infectious diseases; but the two cell types may differ in that MHC molecules may not play a critical role in antigen presentation to most y T cells. (1994) (0)
Short Communication Upregulation of CD94/NKG2A receptors and Qa-1 b ligand during murine cytomegalovirus infection of salivary glands (2007) (0)
+ CD8+ with Class I Molecules on CD4 Thymus and Are Selected by Interactions T Cells in the Liver Arise in the + NK1.1 (2000) (0)
Defective Development of (cid:103) / (cid:100) T Cells in Interleukin 7 Receptor–deﬁcient Mice Is Due to Impaired Expression of T Cell Receptor (cid:103) Genes (1999) (0)
Virus-Infected Cells I Peptide Repertoire in Normal and the Composition and Structure of MHC Class Associated with Antigen Processing Defines Endoplasmic Reticulum Aminopeptidase (2010) (0)
Activation in Hepatic Injury NKG2A Inhibits Invariant NKT Cell (2008) (0)
SLC19A1 transports immunoreactive cyclic dinucleotides (2019) (0)
Inhibitory Receptors Cells Resulting from Engagement of Multiple Cumulative Inhibition of NK Cells and T (2001) (0)
CellsSurveillance of Unhealthy Cells by Natural Killer (2013) (0)
Abstract CN08-03: Oncogenic stress regulates sensitivity of tumor cells to elimination by natural killer cells and T cells (2011) (0)
Lymphocyte development: Editorial overview (2001) (0)
The Role of NKG 2 D Signaling in Inhibition of Cytotoxic T-Lymphocyte Lysis by the Murine Cytomegalovirus Immunoevasin m 152 / gp 40 (2007) (0)
Abstract 3168: Tumor cells express genome-derived DNA in the cytosol (2014) (0)
Expression of Multiple NK Cell Receptors in Viral and Bacterial Infections Induce (2002) (0)
Dependent upon Perforin NKG 2 D Receptor-Ligand Interaction Is Cutting Edge : Tumor Rejection Mediated by Raulet and (2002) (0)
Post-translational regulation of the NKG2D ligand Mult1 in response to cell stess (134.2) (2009) (0)
Abstract IA05: Innate immune defenses against cancer: Potential for mobilizing NK cells for cancer immunotherapy (2021) (0)
STING activation depends on ACBD3 and other phosphatidylinositol 4-phosphate-regulating proteins (2022) (0)
How natural killer cells recognize cancer cells (2008) (0)
in Ly 49-deficient mice Impaired natural killer cell self-education and ' ' missing-self ' ' responses (2012) (0)
STING-Dependent DNA Sensor Pathways in Lymphoma RAE 1 Ligands for the NKG 2 D Receptor Are Regulated (2014) (0)
Cells Immune Surveillance of Unhealthy Cells by Natural Killer (2013) (0)
Ectodomain shedding of the NKG2D ligand MULT1 regulates sensitivity to NK cells (INC6P.400) (2014) (0)
variable region T cell correlates with transcription of the unrearranged genes. (2003) (0)
Humanized Mouse Model Expression Level and Frequency in a HLA Reduces Killer Cell Ig-like Receptor (2013) (0)
Immunology. A sense of something missing. (1992) (0)
Target Cell Recognition by Natural Killer Cells: The NKG2D Receptor-Ligand System (2002) (0)
NKG2D/ligands-mediated immune activation promotes atherosclerosis (2010) (0)
Killer Cell-Mediated Rejection In Vivo TAP-Deficient Tumor Cells from Natural Homologue of HLA-G, Protects Blastocyst MHC, a Putative Murine (2003) (0)
inhibitory receptors specific for self MHC molecules A subset of natural killer cells achieve self-tolerance without expressing (2013) (0)
Disarming of autoreactive NK cells (2009) (0)
This information is current as CD 8 T Cell Response Size or the Effector Memory Phenotype of the Antigen Presentation Has Little Effect on the Murine Cytomegalovirus Interference with (2004) (0)
p53-dependent chemokine expression by tumor cells supports NKG2D-dependent elimination of senescent tumors by natural killer cells (P2115) (2013) (0)
Role of class i mhc and self peptides in nk recognition (1992) (0)
reveals subtle variations in the NK cell repertoire Characterization of a novel NKG2D and NKp46 double-mutant mouse (2013) (0)
Author Correction: SLC19A1 transports immunoreactive cyclic dinucleotides (2020) (0)
584 Powerful synergistic effects of a STING agonist and the IL-2 superkine, H9, in eliciting NK and T cell responses against MHC I- and MHC I+ tumors (2021) (0)
Natural Killer Cells Adapt to Major Histocompatibility Complex: Implications for Hematopoietic Cell Transplantation (2014) (0)
NK cells and NK receptors (WS-007) Chairpersons: Hisashi Arase, Noriko Toyama-Sorimachi (2010) (0)
Cell Gamma Receptor (2008) (0)
NKG2D/ligands-mediated immune activation promotes atherosclerosis (142.7) (2010) (0)
Gene placement and competition control T cell receptor (cid:2) variable region gene rearrangement (2008) (0)
ResponsivenessRegulation of NK Cell Tolerance and Nonhematopoietic Cell Types in the Differential Role of Hematopoietic and (2016) (0)
Induced CD45 Proximity Potentiates Natural Killer Cell Receptor Antagonism (2022) (0)

This paper list is powered by the following services:

Other Resources About David H. Raulet

en.wikipedia.org

What Schools Are Affiliated With David H. Raulet?

David H. Raulet is affiliated with the following schools: